Literature DB >> 6967905

In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells: characterization of the effector lymphocyte.

M Rola-Pleszczynski.   

Abstract

Normal human peripheral blood mononuclear leukocytes (PBML) were incubated (sensitized) in vitro for 6 days with herpes simplex virus type 1 (HSV-1)-infected cells. The sensitized PBML were then tested in a 5-hr 51Cr-release microassay against uninfected or HSV-1-infected target cells. PBML subpopulation-depletion studies revealed that the effector cells were neither B cells nor monocytes, but that their activity was found both in the E-rosetting and the non-E-rosetting lymphocyte fractions. Further separation techniques showed that the effector cells in either fraction expressed an Fc receptor for IgG. In vitro-generated, virus-specific cytotoxic activity thus appeared to be mediated both by a T gamma cell and a special null cell, suggesting possible NK cell involvement.

Entities:  

Mesh:

Year:  1980        PMID: 6967905

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

Review 1.  Natural killer cells in resistance to virus-infected cells.

Authors:  B Rager-Zisman; B R Bloom
Journal:  Springer Semin Immunopathol       Date:  1982

2.  Human antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected autologous and allogeneic cells.

Authors:  S Kohl; C M Moore
Journal:  Immunology       Date:  1983-01       Impact factor: 7.397

3.  Natural cytotoxic cell activity linked to time of recurrence of herpes labialis.

Authors:  M Rola-Pleszczynski; H Lieu
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

4.  Re-evaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1.

Authors:  William P Halford; Jennifer L Maender; Bryan M Gebhardt
Journal:  Virol J       Date:  2005-07-17       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.